USANA (USNA) To Report Earnings Tomorrow: Here Is What To Expect

USANA (USNA) To Report Earnings Tomorrow: Here Is What To Expect

USANA (USNA) To Report Earnings Tomorrow: Here Is What To Expect

Petr Huřťák

Mon, February 16, 2026 at 12:00 PM GMT+9 2 min read

In this article:

USNA

-0.29%

Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results this Tuesday after market hours. Here’s what investors should know.

USANA met analysts’ revenue expectations last quarter, reporting revenues of $213.7 million, up 6.7% year on year. It was a satisfactory quarter for the company, with an impressive beat of analysts’ EBITDA estimates but a miss of analysts’ gross margin estimates.

Is USANA a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting USANA’s revenue to grow 5.8% year on year to $226 million, a reversal from the 3.4% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.41 per share.

USANA Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. USANA has missed Wall Street’s revenue estimates three times over the last two years.

Looking at USANA’s peers in the personal care segment, some have already reported their Q4 results, giving us a hint as to what we can expect. e.l.f. Beauty delivered year-on-year revenue growth of 37.8%, beating analysts’ expectations by 6.4%, and Estée Lauder reported revenues up 5.6%, in line with consensus estimates. e.l.f. Beauty traded down 9.2% following the results while Estée Lauder was also down 16.8%.

Read our full analysis of e.l.f. Beauty’s results here and Estée Lauder’s results here.

There has been positive sentiment among investors in the personal care segment, with share prices up 3.7% on average over the last month. USANA is down 4.9% during the same time and is heading into earnings with an average analyst price target of $39 (compared to the current share price of $20.92).

P.S. STOP buying the AI stocks everyone’s talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments